INmune Bio, Inc. (INMB)
NASDAQ: INMB · Real-Time Price · USD
1.715
+0.065 (3.94%)
Nov 28, 2025, 4:00 PM EST - Market closed
INmune Bio Market Cap
INmune Bio has a market cap or net worth of $45.59 million as of November 28, 2025. Its market cap has decreased by -66.45% in one year.
Market Cap
45.59M
Enterprise Value
18.67M
1-Year Change
-66.45%
Ranking
Category
Stock Price
$1.72
Market Cap Chart
Since February 4, 2019, INmune Bio's market cap has decreased from $77.82M to $45.59M, a decrease of -41.41%. That is a compound annual growth rate of -7.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 26, 2025 | 43.87M | -57.64% |
| Dec 31, 2024 | 103.55M | -48.97% |
| Dec 29, 2023 | 202.92M | 78.35% |
| Dec 30, 2022 | 113.78M | -37.49% |
| Dec 31, 2021 | 182.00M | -21.41% |
| Dec 31, 2020 | 231.57M | 270.69% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Feb 4, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 988.81B |
| Johnson & Johnson | 500.07B |
| AbbVie | 402.36B |
| UnitedHealth Group | 298.66B |
| AstraZeneca | 290.32B |
| Merck & Co. | 259.69B |
| Novartis AG | 251.09B |
| Abbott Laboratories | 223.51B |